Quantbot Technologies LP I Teos Therapeutics, Inc. Transaction History

Quantbot Technologies LP

  • $2.36 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 07, 2023
BUY
$10.95 - $14.6 $51,465 - $68,620
4,700 New
4,700 $51,000
Q4 2022

Feb 13, 2023
SELL
$17.77 - $21.6 $17,094 - $20,779
-962 Reduced 21.86%
3,438 $67,000
Q3 2022

Nov 07, 2022
BUY
$18.6 - $27.25 $19,083 - $27,958
1,026 Added 30.41%
4,400 $83,000
Q2 2022

Aug 09, 2022
BUY
$16.57 - $35.1 $55,907 - $118,427
3,374 New
3,374 $69,000

Others Institutions Holding ITOS

# of Institutions
166
Shares Held
36.6M
Call Options Held
1.95M
Put Options Held
374K
View Full List

About iTeos Therapeutics, Inc.

ITOS Quotes by TradingView
  • Ticker ITOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,575,300
  • Market Cap $257M
  • Description
  • Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...
More about ITOS
Track This Portfolio

Track Quantbot Technologies LP Portfolio

Follow Quantbot Technologies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantbot Technologies LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email